|
Volumn 17, Issue 3, 2010, Pages 345-346
|
The cost of our aging population
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIURETIC AGENT;
WARFARIN;
ALZHEIMER DISEASE;
ARTIFICIAL HEART PACEMAKER;
CARDIAC RESYNCHRONIZATION THERAPY;
CARDIOVASCULAR DISEASE;
CEREBROVASCULAR ACCIDENT;
CONGESTIVE CARDIOMYOPATHY;
CONGESTIVE HEART FAILURE;
DEFIBRILLATOR;
DEPRESSION;
DRUG DOSE TITRATION;
EDITORIAL;
GERIATRIC CARE;
HEALTH CARE COST;
HEALTH CARE SYSTEM;
HEALTH INSURANCE;
HEART ATRIUM FIBRILLATION;
HEART FAILURE;
HEART INFARCTION;
HEART LEFT VENTRICLE FAILURE;
HUMAN;
ISCHEMIC HEART DISEASE;
LIFE EXPECTANCY;
MITRAL VALVE REGURGITATION;
MITRAL VALVE REPAIR;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
AGED, 80 AND OVER;
CARDIOVASCULAR DISEASES;
FEMALE;
HEALTH CARE COSTS;
HEALTH SERVICES FOR THE AGED;
HUMANS;
LIFE EXPECTANCY;
MALE;
QUALITY OF LIFE;
UNITED STATES;
|
EID: 77953305451
PISSN: 10713581
EISSN: None
Source Type: Journal
DOI: 10.1007/s12350-010-9234-2 Document Type: Editorial |
Times cited : (4)
|
References (3)
|